People living with HIV are less likely to mount an adequate immune response, which may put them at higher risk for both serious COVID-19 illness and reduced response to COVID-19 vaccination. The Government of Canada is investing approximately $1.75 million in a study that will assess the immune responses, safety, and effectiveness of COVID-19 vaccination for this vulnerable population that has been understudied with respect to COVID-19.
An open letter sent on behalf of 130 hepatitis and harm reduction advocates to the board and leadership of global funder, Unitaid, demands continuous investment towards HBV and HCV elimination, and to address the needs of 354 million people living with viral hepatitis worldwide.
New treatment combination for hepatitis C virus is an additional affordable option for millions still waiting for access to lifesaving treatments in middle-income countries.
High rates of undiagnosed HIV were found amongst adolescents across five high-burden countries in southern Africa, while the low rates of undetectable viral loads in those accessing treatment raises concerns around treatment effectiveness.
In the unprecedented context of at least 13 variants circulating within the study population subset assessed at this interim analysis, CVnCoV demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity and did not meet prespecified statistical success criteria.
Data published in New England Journal of Medicine shows Pfizer’s tofacitinib meets primary endpoint in Brazilian study in patients hospitalized with COVID-19 pneumonia.
The Russian Federation remains one of the few countries in the world that deports migrants who are living with HIV, so they face a stark choice: go home and lose their income or stay in the country illegally, risking deportation, and without HIV treatment. Foreign citizens living with HIV cannot legally buy or be given antiretroviral therapy in the Russian Federation.
Millions died in poor countries because effective antiretrovirals were out of reach. The same could happen with coronavirus vaccines.
A report from United for Global Mental Health confirmed a longstanding suspicion – that integrating basic mental health and psychosocial services into HIV and TB programs will not only help millions of vulnerable people, but will end these epidemics at a faster rate, and in a cost-effective way.
The World Health Organization hosted a special high-level event on the side-lines of the United Nations High-Level Meeting on HIV/AIDS. The event provided a platform for Member States to reassert their commitment to ending TB deaths among people living with HIV and to deliberate on how they will intensify the response to HIV-associated TB within the context of COVID-19.
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.